Table 2 Patient characteristics validation group (N = 31)
Mean ± SD | Median (P25, P75) | Minimum, Maximum | |
|---|---|---|---|
Age; y | 57 ± 16 | 57 (47, 69) | 21, 82 |
Plasma creatinine; μmol/L | 174.6 ± 100.1 | 157 (87.5, 222.5) | 68.0, 373.0 |
Creatinine, 24hU; mmol | 11.30 ± 3.42 | 11.3 (8.73, 14.50) | 6.54, 17.80 |
CrCl; mL/min/1.73 m2 | 58.4 ± 37.5 | 44.0 (26.7, 89.8) | 14.2, 137.0 |
eCrCl (Cockcroft-Gault); mL/min/1.73 m2 | 54.6 ± 35.2 | 37.9 (36.4, 86.6) | 11.1, 201.1 |
eGFR (4vMDRD); mL/min/1.73 m2 | 49.0 ± 32.3 | 34.0 (20.5, 78.5) | 10.0, 115.0 |
eGFR (CKD-EPI); mL/min/1.73 m2 | 52.0 ± 36.2 | 37.0 (20.5, 84.0) | 10.0, 128.0 |
Body weight; kg | 80.5 ± 13.7 | 76.4 (71.7, 85.3) | 51.4, 113.4 |
Body height; cm | 167 ± 10 | 167 (160, 173) | 147, 187 |
BMI kg/m2 | 28.70 ± 5.3 | 27.5 (25.2, 29.8) | 20.1, 45.4 |
Body Surface Area; m2 | 1.81 ± 0.61 | 1.88 (1.73, 2.01) | 1.51, 2.25 |
BIA Free Fat Mass; kg | 54.0 ± 11.3 | 50.0 (44.3, 57.0) | 36.9, 91.2 |
BIA Body Cell Mass; kg | 25.2 ± 6.3 | 24.4 (19.1, 30.1) | 14.2, 37.7 |
Abdominal circumference; cm | 104 ± 11 | 103 (94, 108) | 91, 115 |
Hip circumference; cm | 99 ± 13 | 100 (95, 104) | 68, 112 |
Waist/hip ratio | 0.99 ± 0.12 | 0.98 (0.95, 1.02) | 0.74, 1.13 |